Jump Trading’s PDL BioPharma, Inc. PDLI Stock Holding History

Jump Trading’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-33,400	Closed	-$124K	–	704
2019 Q1	$124K	Buy	+33,400	New	+$113K	0.04%	463

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jump Trading's PDLI Position: Q2 2019 in Review

Jump Trading sold out of PDL BioPharma, Inc. (PDLI) in Q2 2019, closing a stake of 33,400 shares — an estimated $124K sold.

Jump Trading first reported a position in PDLI in Q1 2019 and held it in 1 quarter. The position peaked at $124K in Q1 2019. 148 funds tracked by Wall St. Rank hold PDLI as of Q2 2019.

Jump Trading reported no remaining PDL BioPharma, Inc. position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 33,400 PDL BioPharma, Inc. shares in Q2 2019, an estimated $124K.
Jump Trading first reported a position in PDL BioPharma, Inc. in Q1 2019 and held it in 1 quarter.
Jump Trading's PDL BioPharma, Inc. position peaked at $124K in Q1 2019.
148 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.